Denosumab-related osteonecrosis of the jaw: A retrospective study.
Fiche publication
Date publication
janvier 2018
Journal
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DOLIVET Gilles, Dr GUILLET-THIBAULT Julie
Tous les auteurs :
Egloff-Juras C, Gallois A, Salleron J, Massard V, Dolivet G, Guillet J, Phulpin B
Lien Pubmed
Résumé
Osteonecrosis of the jaw is a very delicate side effect of Denosumab. The aim of this retrospective study was to assess the occurrence rate of Denosumab-related osteonecrosis of the jaw (DRONJ) at the Cancer Institute of Lorraine (ICL) and to highlight necrosis risk factors.
Mots clés
Denosumab, Oncology, dental management, osteonecrosis of the jaw, retrospective, side effect
Référence
J. Oral Pathol. Med.. 2018 Jan;47(1):66-70